Chiral 4- O-acylterpineol as transdermal permeation enhancers: insights of the enhancement mechanisms of a transdermal enantioselective delivery system for flurbiprofen

Drug Deliv. 2020 Dec;27(1):723-735. doi: 10.1080/10717544.2020.1760403.

Abstract

In order to devise more effective penetration enhancers, 4-O-acylterpineol derivatives which were expected to be hydrolyzed into nontoxic metabolites by esterase in the living epidermis, were synthesized from 4-terpineol (4-TER) enantiomers and straight chain fatty acids. Their promoting activities on the SR-flurbiprofen and its enantiomers were tested across full-thickness rabbit skin, as well as to correlate under in vitro and in vivo conditions. The permeation studies indicated that both d-4-O-acylterpineol and l-4-O-acylterpineol had significant enhancing effects, interestingly, d-4-O-aclyterpineol had higher enhancing effects than l-4-O-aclyterpineol with the exception of d-4-methyl-1-(1-methylethyl)-3-cyclohexen-1-yl octadec-9-enoate (d-4-T-dC18). The mechanism of 4-O-acylterpineol facilitating the drug penetration across the skin was confirmed by Attenuated total reflection-Fourier transformed infrared spectroscopy (ATR-FTIR) and molecular simulation. The mechanism of penetration enhancers promoting drug release was explored by the in vitro release experiment. Finally, a relative safety skin irritation of enhancers was also investigated by in vivo histological evaluation. The present research suggested that d-4-O-aclyterpineol and l-4-O-aclyterpineol could significantly promote the penetration of SR-flurbiprofen and its enantiomers both in vitro and in vivo, with the superiorities of high flux and low dermal toxicity.

Keywords: Chiral 4-O-acylterpineol derivatives; penetration mechanism; permeation enhancers; the in vitro and in vivo correlation; transdermal drug delivery.

MeSH terms

  • Adjuvants, Pharmaceutic / chemical synthesis
  • Adjuvants, Pharmaceutic / chemistry*
  • Adjuvants, Pharmaceutic / pharmacology
  • Administration, Cutaneous
  • Animals
  • Drug Delivery Systems / methods*
  • Drug Liberation
  • Flurbiprofen / administration & dosage*
  • Flurbiprofen / chemistry
  • Flurbiprofen / pharmacokinetics
  • Male
  • Rabbits
  • Skin / drug effects*
  • Skin / metabolism
  • Skin Absorption / drug effects*
  • Solubility
  • Stereoisomerism
  • Transdermal Patch

Substances

  • Adjuvants, Pharmaceutic
  • Flurbiprofen

Grants and funding

This work was supported by following projects: The National Natural Science Foundation of China [grant numbers 81603039], the Natural Science Foundation of Hebei Province [grant numbers H2019209254], North China University of Science and Technology Foundation for Distinguished Young Scholars [grant numbers JQ201713] and Distinguished Young Scholars of Hebei Province.